Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
reasearch assistant. We are a growing chemical-biology research group that aims to develop new molecular tools for neuroscience and cell biology. The researcher will work on different topics: (A
-
THE GROUP We are seeking a highly motivated cell biologist to join Dr. Naomi McGovern's laboratory. The lab works on human mononuclear phagocytes and how their properties are regulated by the local
-
or plant cell wall biology is of advantage. Proficiency in standard molecular cloning (Gateway, GoldenGate) and quantitative PCR and RNAseq analysis is also required. You will be fully involved in
-
The Scarpa lab is a cell and developmental biology research team based in the Department of Physiology, Development and Neuroscience at the University of Cambridge. We are passionate about
-
subject area such as molecular biology, genetics or biochemistry, and extensive knowledge and practical experience of a wide range of conventional and single cell NGS technologies. You will have superior
-
between cell biology and molecular neuroscience. We employ integrated experimental approaches, combining cutting-edge microscopy, biochemistry, omics, and iPSC-derived cell models to understand organelle
-
methods of interest including cell biology and structure determination. We will provide all relevant training in unfamiliar methods. Responsibilities include managing research activities, generating high
-
scientific excellence. Applicants should have a BSc or MSc degree (or equivalent) in a relevant discipline (Biology, Biochemistry, Natural Sciences) as well as a reasonable amount of practical research
-
cells of the immune system that kill virally infected and cancer cells. Our research combines cell biology and immunology, using genetic approaches including CRISPR and single cell RNA sequencing
-
barcoding and fate-tracking, molecular biology and high throughput RNA- and DNA-sequencing. The applicant will also have the opportunity to utilise platforms for high-throughput CRISPR/Cas9-based mutagenesis